Thank you for downloading this publication. Please let us know why you chose this publication:
Why are you interested in this publication?
What organisation do you represent?
You will only need to complete this form once per browser/device
How do you prefer to read or receive publications?

We may contact you for feedback on the publication you have downloaded. If you do not want to be contacted, please leave the email field blank. Your information will never be shared with any third party.

Donate Visit Malaria Consortium U.S.
  • Visit Malaria Consortium U.S.
  • What we do
    • Diseases
    • Policy development and advocacy
    • Research
    • Learning
  • Our expertise
  • Where We Work
    • Africa
    • Burkina Faso
    • Chad
    • Ethiopia
    • Mozambique
    • Nigeria
    • South Sudan
    • Uganda
    • Asia
    • Cambodia
    • Myanmar
    • Thailand
  • Projects
    • Project database
    • Featured projects
    • Past projects
  • Publications
  • Media centre
    • Newsletters
    • News
    • Blog
    • Videos
    • Webinars
    • Press and media
    • Photo stories
    • Voices of experience
  • About us
    • Who we are
    • Governance
    • Aid transparency
    • Dr Sylvia Meek
    • Annual reviews
    • Policies and procedures
    • Careers
    • Tenders
    • Contact us
    • Malaria Consortium U.S.
  • Support us
  • Home
  • »
  • Projects Database
  • »
  • Smc mozambique bmgf phase 2

Share this page

Projects

Projects Database

SMC Mozambique BMGF Phase 2

The study aims to test the feasibility, effectiveness and chemoprevention efficacy of SMC with SPAQ in an area of Mozambique where malaria transmission is highly seasonal.This implementation research study uses a convergent mixed-methods approach. SMC will be implemented in four monthly cycles between November 2021 and February 2022. The research will involve documenting the process of further adapting the intervention to the context in Mozambique, as well as conducting a representative end-of-round household survey to determine coverage and quality of SMC implementation. 

 

 


Start Date:15/09/2021End Date:31/08/2022Country:MozambiqueRegion:AfricaKeywords:Malaria, Seasonal malaria chemopreventionDonor:Bill & Melinda Gates FoundationBudget:1862922.00(USD)

 

Back

Resources

  • Contact us
  • Latest news
  • Media centre
  • Aid transparency

Malaria Consortium Strategy 2021-2025

Related Resources

Photo for: Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020 Resource: Annual review
Published 16 April 2021

Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020

Sign up for our newsletters here:

  • Visit Malaria Consortium U.S.
  • What we do
    • Diseases
    • Policy development and advocacy
    • Research
    • Learning
  • Our expertise
  • Where We Work
    • Africa
    • Burkina Faso
    • Chad
    • Ethiopia
    • Mozambique
    • Nigeria
    • South Sudan
    • Uganda
    • Asia
    • Cambodia
    • Myanmar
    • Thailand
  • Projects
    • Project database
    • Featured projects
    • Past projects
  • Publications
  • Media centre
    • Newsletters
    • News
    • Blog
    • Videos
    • Webinars
    • Press and media
    • Photo stories
    • Voices of experience
  • About us
    • Who we are
    • Governance
    • Aid transparency
    • Dr Sylvia Meek
    • Annual reviews
    • Policies and procedures
    • Careers
    • Tenders
    • Contact us
    • Malaria Consortium U.S.
  • Support us

Language Options: English | Français

© 2022 Malaria Consortium | Charity No. 1099776 | Company No. 4785712 | Privacy notice | Modern Slavery Statement | United Nations Global Compact